Frederic M Waldman MD
Anatomic Pathology, Clinical Pathology
Medical Director, Cancer Diagnostics Quest Diagnostics Nichols Institute
Join to view full profile
1600 Divisadero StSan Francisco, CA 94143
Phone+1 415-353-7241
Fax+1 415-476-4150
Dr. Waldman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1980 - 1984
New York University School of MedicineClass of 1980
Certifications & Licensure
CA State Medical License 1982 - 2015
American Board of Pathology Anatomic Pathology & Clinical Pathology
Clinical Trials
- Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ Start of enrollment: 2002 Feb 19
Publications & Presentations
PubMed
- 12 citationsPrognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project.Gang Wang, Peter C. Black, Peter J. Goebell, Lingyun Ji, Carlos Cordon-Cardo
Urologic Oncology. 2021-02-06 - 81 citationsThe molecular basis of breast cancer pathological phenotypesYujing J. Heng, Susan C. Lester, Gary M. Tse, Rachel E. Factor, Kimberly H. Allison
The Journal of Pathology. 2017-02-01 - 1 citationsMutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor SamplesHeather R. Sanders, Kevin Qu, Hai-Rong Li, Lin Ma, Cindy Barlan
Molecular Diagnosis & Therapy. 2016-04-15
Press Mentions
With Fall 2017 Cycle, UCSF’s Resource Allocation Program (RAP) Celebrates 10 Years of FundingAugust 25th, 2017
Grant Support
- Immunohistochemistry And Molecular PathologyNational Cancer Institute2007–2011
- Predictive Markers In Metastatic Renal CancerNational Cancer Institute2008–2010
- Bladder Cancer Risk And Genomic AlterationsNational Cancer Institute2007–2010
- Renal Cancer Genomic Alterations And Environmental Risk(Rmi)National Cancer Institute2007
- Renal Cancer Genomic Alterations And Environmental RiskNational Cancer Institute2003–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: